295 related articles for article (PubMed ID: 33952697)
21. ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells.
Wang X; Wang Y; Gu J; Zhou D; He Z; Wang X; Ferrone S
Sci Rep; 2017 Aug; 7(1):9687. PubMed ID: 28852196
[TBL] [Abstract][Full Text] [Related]
22. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer.
Kozlova N; Wottawa M; Katschinski DM; Kristiansen G; Kietzmann T
Oncotarget; 2017 Feb; 8(6):9885-9898. PubMed ID: 28038470
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis.
Wong CC; Zhang H; Gilkes DM; Chen J; Wei H; Chaturvedi P; Hubbi ME; Semenza GL
J Mol Med (Berl); 2012 Jul; 90(7):803-15. PubMed ID: 22231744
[TBL] [Abstract][Full Text] [Related]
25. Kindlin-2 interacts with and stabilizes EGFR and is required for EGF-induced breast cancer cell migration.
Guo B; Gao J; Zhan J; Zhang H
Cancer Lett; 2015 Jun; 361(2):271-81. PubMed ID: 25790908
[TBL] [Abstract][Full Text] [Related]
26. ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer.
Wang R; Gao D; Chen C; Fan G; Cheng H; Tao Y; Lu J; Tian J; Wang Y; Wang Z
Clin Transl Oncol; 2023 May; 25(5):1425-1435. PubMed ID: 36512304
[TBL] [Abstract][Full Text] [Related]
27. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
28. An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer.
Li H; Duhachek-Muggy S; Qi Y; Hong Y; Behbod F; Zolkiewska A
Breast Cancer Res Treat; 2012 Oct; 135(3):759-69. PubMed ID: 22926263
[TBL] [Abstract][Full Text] [Related]
29. HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment.
Nagpal N; Ahmad HM; Chameettachal S; Sundar D; Ghosh S; Kulshreshtha R
Sci Rep; 2015 Apr; 5():9650. PubMed ID: 25867965
[TBL] [Abstract][Full Text] [Related]
30. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
31. The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.
Liang Y; Xu X; Wang T; Li Y; You W; Fu J; Liu Y; Jin S; Ji Q; Zhao W; Song Q; Li L; Hong T; Huang J; Lyu Z; Ye Q
Cell Death Dis; 2017 Jul; 8(7):e2928. PubMed ID: 28703807
[TBL] [Abstract][Full Text] [Related]
32. TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway.
Jin W; Chen BB; Li JY; Zhu H; Huang M; Gu SM; Wang QQ; Chen JY; Yu S; Wu J; Shao ZM
Mol Cell Biol; 2012 Jan; 32(1):50-63. PubMed ID: 22025675
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia Alters the Response to Anti-EGFR Therapy by Regulating EGFR Expression and Downstream Signaling in a DNA Methylation-Specific and HIF-Dependent Manner.
Mamo M; Ye IC; DiGiacomo JW; Park JY; Downs B; Gilkes DM
Cancer Res; 2020 Nov; 80(22):4998-5010. PubMed ID: 33023947
[TBL] [Abstract][Full Text] [Related]
34. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
Zhang X; Diaz MR; Yee D
Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
[TBL] [Abstract][Full Text] [Related]
35. HIF-1α, NOTCH1, ADAM12, and HB-EGF are overexpressed in mucoepidermoid carcinoma.
Branco DC; da Costa NMM; Abe CTS; Kataoka MSDS; Pinheiro JJV; Alves Júnior SM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Jan; 127(1):e8-e17. PubMed ID: 30415904
[TBL] [Abstract][Full Text] [Related]
36. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.
Sethuraman A; Brown M; Krutilina R; Wu ZH; Seagroves TN; Pfeffer LM; Fan M
Breast Cancer Res; 2018 Oct; 20(1):117. PubMed ID: 30285805
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.
Elbaz M; Nasser MW; Ravi J; Wani NA; Ahirwar DK; Zhao H; Oghumu S; Satoskar AR; Shilo K; Carson WE; Ganju RK
Mol Oncol; 2015 Apr; 9(4):906-19. PubMed ID: 25660577
[TBL] [Abstract][Full Text] [Related]
38. ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.
Fröhlich C; Klitgaard M; Noer JB; Kotzsch A; Nehammer C; Kronqvist P; Berthelsen J; Blobel C; Kveiborg M; Albrechtsen R; Wewer UM
Biochem J; 2013 May; 452(1):97-109. PubMed ID: 23458101
[TBL] [Abstract][Full Text] [Related]
39. Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling.
Du WW; Yang BB; Shatseva TA; Yang BL; Deng Z; Shan SW; Lee DY; Seth A; Yee AJ
PLoS One; 2010 Nov; 5(11):e13828. PubMed ID: 21079779
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
